The principal objective of this study was to examine the effects of mutant ATXN2 on genome-wide expression of spinal cord (SC) genes and integrate changes into a framework of previously described transcriptomic changes in ALS models. This evidence concerns the gene ATXN2 and amyotrophic lateral sclerosis.